Page 117 - ESHRE2019
P. 117
Vittorio Pengo et al. Blood 2018;132:1365-1371
©2018 by American Society of Hematology
Cumulative incidence of events (death, thromboembolic events, and major bleeding) in the rivaroxaban group (dotted and dashed line) and in the warfarin group (solid line).
Vittorio Pengo et al. Blood 2018;132:1365-1371
©2018 by American Society of Hematology
112
PRECONGRESS COURSE 06 I VIENNA, AUSTRIA – 23 JUNE 2019 115
